<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03402113</url>
  </required_header>
  <id_info>
    <org_study_id>Gulou ICU</org_study_id>
    <nct_id>NCT03402113</nct_id>
  </id_info>
  <brief_title>Sedation Protocols and Skeletal Muscle Metabolism in Mechanical Ventilated Patients</brief_title>
  <official_title>The Effect of Different Sedation Protocols on Skeletal Muscle Metabolism in Mechanical Ventilated Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Medical Association</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Medical Association</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the effects of different sedation protocols on skeletal muscle metabolism in
      mechanical ventilated patients in ICU. Mechanical ventilated patients who are anticipated to
      stay in ICU for more than 5 days are enrolled and randomly assigned to the following three
      groups, interventional group(dexmedetomidine), control group(midazolam) and no sedation
      group. Serum, CT scan of intercostal muscles, ultrasound evaluation of quadriceps femoris are
      obtained.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 20, 2017</start_date>
  <completion_date type="Anticipated">January 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>acute muscle wasting</measure>
    <time_frame>From date of randomization to extubation,up to 7 days</time_frame>
    <description>measured by 3-MH release in serum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>28-day mortality</measure>
    <time_frame>From date of randomization to date of death from any cause,up to 28 days</time_frame>
    <description>death rate within 28 days after mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of ICU stay</measure>
    <time_frame>From date of randomization to date of to discharge or death,up to 28 days</time_frame>
    <description>time from enrollment to discharge or die</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Hypercatabolism</condition>
  <condition>Sedative, Hypnotic, or Anxiolytic Use Disorders</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine consistent infusion as sedative.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Midazolam group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Midazolam consistent infusion as sedative.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>consistent infusion at a loading dose of 0.15ug/kg/h, increased by 0.15ug/kg/h, with a maximum dose of 1.5ug/kg/h.</description>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>consistent infusion at a loading dose of 1mg/h, increased by 1mg/h, with a maximum dose of 10mg/h.</description>
    <arm_group_label>Midazolam group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  mechanical ventilated for more than 48h

          -  18-80 years

          -  stay in ICU for more than 5 days

        Exclusion Criteria

          -  already participated in other clinical trials

          -  pregnancy or lactation

          -  lower limb amputation

          -  primary neuro-muscular disease

          -  disseminated tumor or accepted special therapy

          -  alcohol abuse

          -  severe liver dysfunction(Child-Push C)

          -  unstable angina/acute myocardial infarction

          -  heart rates＜50bpm

          -  all kinds dialysis

          -  severe burn

          -  epidural anesthesia

          -  severe neurological disease（acute stroke, uncontrollable epilepsy, severe dementia,
             etc）
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Wenkui Yu, Ph.D</last_name>
    <phone>13701582986</phone>
    <email>yudrnj@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Qin Gu, Master</last_name>
    <phone>13705150348</phone>
    <email>icuguqin@sina.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Affliated Drum Tower Hospital, Medical School of Nanjing University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenkui Yu</last_name>
      <phone>02568182222</phone>
      <phone_ext>60506</phone_ext>
      <email>yudrnj@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 26, 2017</study_first_submitted>
  <study_first_submitted_qc>January 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2018</study_first_posted>
  <last_update_submitted>March 26, 2018</last_update_submitted>
  <last_update_submitted_qc>March 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data is not available to other researchers after publication.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

